Oral Topotecan in Previously Treated Advanced NSCLC
During the entire time I've been commenting on the most evidence-based and commonly used agents for previously treated patients, I've focused on taxotere, alimta, and tarceva (example in prior post here). In fact, that overlooks an agent that has actually been tested in a large study and been found to have similar activity to taxotere, but it remains pretty much an afterthought.